This invention discloses a new type of drug for treating cancer, comprising an alkaline salt that can reduce localized acidity levels in cancerous tumors. This drug comprises a water-soluble alkaline salt (such as a potassium salt) of a benzene ring having several pendant groups, including at least one acid group. One example comprises a vanillin derivative referred to herein as HMSBA, which is hydroxy-methoxy-sulfonic acid-benzyl alcohol. To prepare an alkaline salt solution for injection into the bloodstream of a cancer patient, a sufficient quantity of an alkali such as potassium hydroxide is added to a solution of HMSBA in water or saline buffer, until the pH of the mixture increases to about 7.3 to 7.4. A sufficient quantity of the aqueous solution is injected into the blood of a cancer patient to reduce the acidity of extracellular fluids in one or more cancerous neoplasms inside the body. When the acidity of such tumors is reduced from cancerous acidic levels to more physiologically normal levels, the patient's immune system can function more effectively to help fight and destroy cancer cells in the tumor. This treatment has been tested on humans as well as lab animals, and it has been shown to be very effective in reducing the size and severity of tumors. In a number of animals and people treated by this method, it resulted in apparently complete remission and cure.

Estate of Boris D. Akkerman

Alkaline salt solutions for treating cancerous tumors

Disclosed is an agent which has a destructive effect on malignant tumors and contains alpha-ketoglutaric acid, N-acetyl-seleno-L-methionine, N-acetyl-L-methionine, and a compound that is capable of forming azomethine and is selected among the group 5-hydroxymethylfurfural, dehydroascorbic acid, maltol, and vanillin as an active substance, 5-hydroxymethylfurfural being preferred. The inventive agent can be used in the form of an infusion, in an oral or rectal form of administration, or as an irrigation in cancer therapy.

C.Y.L. Pharmazeutika GmbH

Ferdinand; Peter

Agent having a destructive effect on malignant tumors and method for the production thereof

The present invention relates to a composition for the prevention or treatment of diseases associated with angiogenesis, and in detail, to a composition comprising the extract of Cnidium officinale Makino or the fraction thereof for the prevention or treatment of diseases associated with angiogenesis. The present invention also provides 3-butyl-7-hydroxyphthalide, vanillin, coniferyl ferulate, and falcarindiol as active compounds. The composition of the present invention inhibits angiogenesis, so that it can be applied to the prevention or treatment of diseases related to angiogenesis, such as arthritis, diabetic retinopathy, psoriasis, and cancer.

vanillin/syöpä

Alkaline salt solutions for treating cancerous tumors

Agent having a destructive effect on malignant tumors and method for the production thereof

Composition for the prevention or treatment of diseases associated with angiogenesis

Täydellisin lääketieteellinen tietokanta tieteen tukemana